Sodium Lowering and Urinary Protein Reduction Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Chronic Kidney DiseaseAlbuminuria
Interventions
BEHAVIORAL

Low Sodium Diet

Once randomized to the Intervention program, study participants will be grouped into intervention cohorts of approximately 10 participants per group to facilitate group counseling sessions. Both the intensive intervention phase and the maintenance phase will include individual and group behavioral modification counseling designed to facilitate a reduction in dietary sodium intake. Success of the intervention will be assessed by comparing the urine sodium measurements from 24-hour urine collections performed at screening, 12 weeks and 24 weeks.

Trial Locations (1)

70112

Tulane University, New Orleans

All Listed Sponsors
lead

Tulane University School of Public Health and Tropical Medicine

OTHER

NCT02945969 - Sodium Lowering and Urinary Protein Reduction Trial | Biotech Hunter | Biotech Hunter